![]() This prevents pharmacies from being truly patient-focused and able to deliver the best possible care. In fact, when the focus is on the product rather than the patient, the pharmacy’s incentives tend to emphasize monthly profits. ![]() This is critical for overcoming the limitations of the standard specialty pharmacy and hub service provider, which rely too heavily on technology solutions that fail to encompass human needs and variability. Ideally, this concentration of services depends upon a team of care coordinators, pharmacists, nurses, and other specialists who are fully dedicated to the disease state, patient community, and therapy. For this reason, a patient-first strategy addresses all variables around collecting data, while maintaining frequent communication with patients and their families to ensure compliance and positive outcomes. ![]() Specialty patients need a significant amount of assistance throughout the care continuum and have much to gain from high-touch service. What’s more, dedicated clinical teams are empowered to seamlessly eliminate treatment gaps for the patient. This higher level of care continuity strengthens communication, yields rich data for more informed decision-making, and improves the overall patient experience. During the remaining months of the COVID-19 pandemic and beyond, pharmaceutical companies, pharmacists, physicians, and other members of the care team can better address compliance and adherence to treatment when the patient is at the center of all care coordination.īecause specialty patients require a high level of therapy adherence support, targeted programs and services that deliver specialized expertise can go well beyond the scope of capabilities provided by traditional care organizations that are simply built for scale.Ī patient-first approach allows physicians, specialty pharmacy, patients, and care coordinators to connect effortlessly, rather than operating independently. Stakeholders looking to optimize the quality of care, impact the patient experience, and improve outcomes for the 30 million Americans living with a range of 7,000 rare or orphan diseases must take a patient-first approach. Addressing Unique Needs of Specialty Drug Patients, Enhancing Care Quality, and Improving Outcomes
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |